Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 9, 2012, Pages 2176-2185

  Arumugam, Somasundaram ^a   Thandavarayan, Rajarajan A ^a   Veeraveedu, Punniyakoti T ^b   Nakamura, Takashi ^a   Arozal, Wawaimuli ^a   Sari, Flori R ^a   Giridharan, Vijayasree V ^a   Soetikno, Vivian ^a   Palaniyandi, Suresh S ^c   Harima, Meilei ^a   Suzuki, Kenji ^d   Nagata, Masaki ^d   Kodama, Makoto ^d   Watanabe, Kenichi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Apoptosis; Dilated cardiomyopathy; Edaravone; Endoplasmic reticulum stress; Fibrosis; Oxidative stress

Indexed keywords

ANTIOXIDANT; CARDIAC MYOSIN; CASP3 PROTEIN, RAT; CASPASE 3; CYTOCHROME C; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENAZONE; PHENYLMETHYLPYRAZOLONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONGESTIVE CARDIOMYOPATHY; DOWN REGULATION; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; GENETICS; HEART MUSCLE FIBROSIS; HEART VENTRICLE; LEWIS RAT; MALE; METABOLISM; MYOCARDITIS; NICK END LABELING; OXIDATIVE STRESS; PATHOLOGY; RAT; SWINE; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ANTIPYRINE; APOPTOSIS; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; CARDIAC MYOSINS; CARDIOMYOPATHY, DILATED; CASPASE 3; CYTOCHROMES C; DOWN-REGULATION; ENDOMYOCARDIAL FIBROSIS; ENDOPLASMIC RETICULUM STRESS; HEART VENTRICLES; IN SITU NICK-END LABELING; MALE; MYOCARDITIS; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; SWINE;

EID: 84865422645     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01526.x     Document Type: Article

References (42)

1. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation 2001; 34: 199-204.
2. Kodama M, Hanawa H, Saeki M, et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994; 75: 278-84.
3. Okura Y, Yamamoto T, Goto S, et al. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 1997; 29: 491-502.
4. Ishiyama S, Hiroe M, Nishikawa T, et al. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J Immunol 1998; 161: 4695-701.
5. Ishiyama S, Hiroe M, Nishikawa T, et al. Nitric oxide contributes the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997; 95: 489-96.
6. Belch JJ, Bridges AB, Scott N, et al. Oxygen free radicals and congestive heart failure. Br Heart J. 1991; 65: 245-8.
7. Yamaguchi K. Effects of water deprivation on immunoreactive angiotensin II levels in plasma, cerebroventricular perfusate and hypothalamus of the rat. Acta Endocrinol. 1981; 97: 137-44.
8. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991; 9: 3-15.
9. Tada S, Nakamoto N, Kameyama K, et al. Clinical usefulness of edaravone for acute liver injury. J Gastroenterol Hepatol 2003; 18: 851-7.
10. Onogi H, Minatoguchi S, Chen XH, et al. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits. Clin Exp Pharmacol Physiol 2006; 33: 1035-41.
11. Tsujimoto I, Hikoso S, Yamaguchi O, et al. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 2005; 45: 921-6.
12. Shimazaki H, Watanabe K, Veeraveedu PT, et al. The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis. Free Radic Res 2010; 44: 1082-90.
13. Kodama M, Matsumoto Y, Fujiwara M, et al. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990; 57: 250-62.
14. Watanabe K, Nakazawa M, Fuse K, et al. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001; 104: 1098-100.
15. Thandavarayan RA, Watanabe K, Ma M, et al. Dominant-negative p38alpha mitogen activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus. Am J Physiol Heart Circ Physiol. 2009; 297: H911-9.
16. Thandavarayan RA, Watanabe K, Sari FR, et al. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. Free Radic Biol Med 2010; 49: 1422-31.
17. Sukumaran V, Watanabe K, Veeraveedu PT, et al. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy. Exp Biol Med. 2010; 235: 1338-46.
18. Watanabe K, Sukumaran V, Veeraveedu PT, et al. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis. Inflamm Allerg Drug Targets 2011; 10: 218-25.
19. Arozal W, Watanabe K, Veeraveedu PT, et al. Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. Free Radic Res 2010; 44: 1369-77.
20. Miller FJ Jr, Gutterman DD, Rios CD, et al. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82: 1298-305.
21. Thandavarayan RA, Watanabe K, Ma M, et al. 14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. Biochem Pharmacol 2008; 75: 1797-806.
22. Kwon KB, Kim EK, Han MJ, et al. Induction of apoptosis by Radix Paeoniae Alba extract through cytochrome c release and the activations of caspase-9 and caspase-3 in HL-60 cells. Biol Pharm Bull 2006; 29: 1082-6.
23. Sukumaran V, Watanabe K, Veeraveedu PT, et al. Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis. Int J Biol Sci. 2011; 7: 154-67.
24. Prasad K, Gupta JB, Kalra J, et al. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 1996; 28: 375-85.
25. Muthalif MM, Karzoun NA, Gaber L, et al. Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 2000; 36: 604-9.
26. Ming W, Li S, Billadeau DD, et al. The Rac effector p67phox regulates phagocyte NADPH oxidase by stimulating Vav1 guanine nucleotide exchange activity. Mol Cell Biol 2007; 27: 312-23.
27. Kyaw M, Yoshizumi M, Tsuchiya K, et al. Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. Acta Pharmacol Sin 2004; 25: 977-85.
28. Zhang YM, Wang Y, Liu XH, et al. Cardioprotective effect of edaravone pharmacological postconditioning on acute myocardial ischemia/reperfusion injury: experiment with rats. Zhonghua Yi Xue Za Zhi. 2008; 88: 2558-61.
29. Cesselli D, Jakoniuk I, Barlucchi L, et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001; 89: 279-86.
30. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192: 1-15.
31. Chandrashekhar Y, Narula J. Death hath a thousand doors to let out life. Circ Res 2003; 92: 710-4.
32. Juhasz B, Der P, Szodoray P, et al. Adrenocorticotrope hormone fragment (4-10) attenuates the ischemia/reperfusion-induced cardiac injury in isolated rat hearts. Antioxid Redox Signal 2007; 9: 1851-61.
33. Kovacs P, Bak I, Szendrei L, et al. Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 501-7.
34. Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 2002; 7: 335-45.
35. Bhimji S, Godin DV, McNeill JH. Myocardial ultrastructural changes in alloxan-induced diabetes in rabbits. Acta Anat. 1986; 125: 195-200.
36. Mao W, Fukuoka S, Iwai C, et al. Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine. Am J Physiol Heart Circ Physiol. 2007; 293: H1636-45.
37. Takimoto E, Kass DA. Role of oxidativestress in cardiac hypertrophy and remodeling. Hypertension 2007; 49: 241-8.
38. Bendall JK, Rinze R, Adlam D, et al. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res 2007; 100: 1016-25.
39. Tanaka H, Ueda H, Fukuchi H, et al. Antifibrotic effect of edaravone in rat liver cirrhosis induced by dimethylnitrosamine. Clin Exp Med. 2009; 9: 229-33.
40. Nimata M, Okabe TA, Hattori M, et al. MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. Am J Physiol Heart Circ Physiol. 2005; 289: H2514-8.
41. Okabe TA, Kishimoto C, Hattori M, et al. Cardioprotective effects of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel free radical scavenger, on acute autoimmune myocarditis in rats. Exp Clin Cardiol. 2004; 9: 177-80.
42. Watanabe K, Ma M, Wen J, et al. Effects of edaravone in heart of aged rats after cerebral ischemia-reperfusion injury. Biol Pharm Bull 2007; 30: 460-4.